These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7672707

  • 1. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Patsner B, Greenberg S.
    Gynecol Oncol; 1995 Sep; 58(3):386-8. PubMed ID: 7672707
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH, Wen XP, Hu L.
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [Abstract] [Full Text] [Related]

  • 3. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB, Clamon GH, Baker LH.
    Cancer; 1998 Apr 01; 82(7):1288-95. PubMed ID: 9529020
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ, Agarwal K, Zornig C, Schwarz R, Dietel M, Hossfeld DK.
    Cancer Chemother Pharmacol; 1993 Apr 01; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [Abstract] [Full Text] [Related]

  • 6. Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
    Elias A, Ryan L, Aisner J, Antman KH.
    Semin Oncol; 1990 Apr 01; 17(2 Suppl 4):41-9. PubMed ID: 2110385
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD, Antman KH.
    Cancer Treat Rep; 1986 Jul 01; 70(7):827-33. PubMed ID: 3087617
    [Abstract] [Full Text] [Related]

  • 8. Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
    Lee KW, Kim YJ, Kim JH, Bang SM, Chung JH, Lee JS.
    Jpn J Clin Oncol; 2011 Mar 01; 41(3):430-3. PubMed ID: 20926411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged survival of stage IV malignant mixed Müllerian tumor of the ovary after carboplatin, mesna, ifosfamide, and cis-platin chemotherapy: case report.
    Di Vagno G, Cormio G, Loverro G, Melilli GA, Di Gesù G, Selvaggi L.
    J Chemother; 1998 Oct 01; 10(5):418-21. PubMed ID: 9822362
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
    Sit AS, Price FV, Kelley JL, Comerci JT, Kunschner AJ, Kanbour-Shakir A, Edwards RP.
    Gynecol Oncol; 2000 Nov 01; 79(2):196-200. PubMed ID: 11063643
    [Abstract] [Full Text] [Related]

  • 12. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
    Minobe S, Todo Y, Suzuki Y, Aoyagi Y, Umazume T, Okamoto K, Kato H.
    J Obstet Gynaecol Res; 2011 Jun 01; 37(6):645-9. PubMed ID: 21375676
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.
    J Clin Oncol; 2005 Jun 20; 23(18):4031-8. PubMed ID: 15767644
    [Abstract] [Full Text] [Related]

  • 14. Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas.
    Pearl ML, Inagami M, McCauley DL, Valea FA, Chalas E, Fischer M.
    Int J Gynecol Cancer; 2002 Jun 20; 12(6):745-8. PubMed ID: 12445253
    [Abstract] [Full Text] [Related]

  • 15. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX, Zhang YT, Shang JT, Xu Z, Geng Y, Li SM, Shi F, Wu YY.
    Ai Zheng; 2006 Aug 20; 25(8):1048-51. PubMed ID: 16965692
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
    Bui BN, Chevallier B, Chevreau C, Krakowski I, Peny AM, Thyss A, Maugard-Louboutin C, Cupissol D, Fargeot P, Bonichon F.
    J Clin Oncol; 1995 Oct 20; 13(10):2629-36. PubMed ID: 7595717
    [Abstract] [Full Text] [Related]

  • 17. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD, Elias AD.
    Hematol Oncol Clin North Am; 1995 Aug 20; 9(4):765-85. PubMed ID: 7490240
    [Abstract] [Full Text] [Related]

  • 18. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
    Pisters PW.
    J Clin Oncol; 2006 Feb 01; 24(4):549-51. PubMed ID: 16446327
    [No Abstract] [Full Text] [Related]

  • 19. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
    Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH.
    J Clin Oncol; 1989 Sep 01; 7(9):1208-16. PubMed ID: 2504890
    [Abstract] [Full Text] [Related]

  • 20. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec 01; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.